Almac has launched a new reagent offering providing homogeneous full-length histones with defined patterns of modification for researchers exploring key drug targets in the field of epigenetics.   The reagents will be offered through a catalogue of modified histones and additionally as a custom synthesis service to meet specific customer needs. The modified histone reagent provision expands Almac’s range of FLEXYTE FLT assays for epigenetic targets.   “This is a first class example of how Almac ...